Corporate Technology - Rolf Hellinger
Corporate Technology - Rolf Hellinger
Corporate Technology - Rolf Hellinger
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Research Partnerships<br />
Beth Israel Deaconess Medical Center in<br />
Boston: Detecting Cancer Cells with Light<br />
When breast cancer is detected, the first thing the doctor wants to know is<br />
whether it has spread to nearby lymph nodes. Unfortunately, the only way of<br />
determining this is to remove all potentially-affected nodes, and there are<br />
typically 30 of them in a woman’s armpit. With a view to minimizing surgical<br />
intervention, John V. Frangioni, M.D. PhD of Boston’s Beth Israel Deaconess<br />
Medical Center has developed a new imaging system that allows doctors to<br />
see exactly which lymph nodes a tumor drains into. Whether cancer cells have<br />
actually migrated to these nodes can be determined after the nodes have<br />
been removed. Known as Fluorescence-Assisted Resection and Exploration<br />
(FLARE), the system uses unique medical image fusion and visualization<br />
software developed by Siemens <strong>Corporate</strong> Research (SCR) that combines a<br />
visible light image of the area of interest with an image of the invisible<br />
infrared light reflected from a fluorescent substance. Injected into the area<br />
surrounding the tumor, the substance rapidly finds its way from the tumor to<br />
the nodes it drains into. The resulting hybrid image, which appears in real<br />
time on a color monitor, displays concentrations of brightness at the tumor<br />
and at its associated nodes, as well as a river of light beneath the skin<br />
indicating the fluid’s drainage path. And that’s just for starters. Optical<br />
systems could detect a spectrum of physiological processes indicative of<br />
cancer, such as changes in oxygen saturation and hemoglobin and water<br />
concentrations in tissues long before any anatomical or structural changes are<br />
visible to a surgeon’s eye. Such a tool could have far-reaching consequences .<br />
By providing feedback within hours regarding a tumor’s response to a new<br />
medication, in vivo optical imaging could inexpensively accelerate and<br />
personalize drug testing as well as patient treatment for shallow lesions as<br />
well as those that could be approached with future endoscopic devices. With<br />
this in mind, SCR researchers are working with the Beckman Laser Institute at<br />
the University of California in Irvine, to develop a novel software imaging<br />
platform for a hand-held laser and broadband diffuse optical spectroscopy<br />
probe that would work in much the same way as does an ultrasound<br />
transducer — but with light instead of sound. The device could be applied<br />
directly to the surface of the breast, where it will emit light at a range of<br />
wavelengths, enabling quantification of many physiological properties.<br />
44 <strong>Corporate</strong> <strong>Technology</strong><br />
Research in Moscow, St. Petersburg, Novosibirsk,<br />
and Tomsk: Strength through Cooperation<br />
Since its founding in 2005, CT Russia has accomplished a great deal (see p.<br />
28) — and much of this success is due to the approximately 20 research<br />
partnerships it has with leading Russian research institutes, universities,<br />
and industrial companies. CT researchers are now working on new types of<br />
combustion concepts for integrated gasification combustion cycle (IGCC)<br />
processes in cooperation with experts from the Moscow Engineering and<br />
Physics Institute, who have developed an experimental gas burner for the<br />
Siemens researchers to use in extensive tests of the new concept.<br />
CT is also working together with the Institute of Strength Physics and<br />
Materials Sciences (ISPMS) in Tomsk, Siberia, on the development of<br />
nanostructured ceramics for use in gas turbines. These new ceramic<br />
coatings are more ductile and longer-lasting than their current counterparts,<br />
which means that the service life of the turbines they’re installed in<br />
can be extended and the turbines themselves can be exposed to higher<br />
stresses without damage. All of this results in savings for power plant<br />
operators. ISPMS is using its expertise and tools to develop the nanostructured<br />
ceramics, and Siemens researchers are investigating how to optimally<br />
install the material in a gas turbine.<br />
Technicians need to react quickly if a complex system like a gas turbine<br />
develops a fault, as shutdowns can be very expensive. Russian researchers<br />
at Siemens are thus working with the renowned State Polytechnical<br />
University in St. Petersburg to develop intelligent software solutions that<br />
recognize and report potential defects before they occur. Such solutions<br />
monitor the operation of the system in question on the basis of<br />
programmed parameters such as oscillation and environmental data.<br />
Siemens is responsible for the software expertise here, while the university<br />
conducts practical tests, handles implementation, and optimizes the<br />
analysis system. A very different type of optimization was developed by<br />
CT researchers in conjunction with Russian oil company Rosneft. Together,<br />
they developed a chemical process to raise the pressure of less active oil<br />
deposits and thus enable the corresponding oil fields to be returned to<br />
production. CT carried out the modeling and simulations for this project,<br />
while Rosneft was responsible for the experimental part.